Deutsche Bank’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-194,032
| Closed | -$1.25M | – | 3621 |
|
|
2023
Q2 | $1.25M | Sell |
194,032
-109,438
| -36% | -$707K | ﹤0.01% | 1860 |
|
|
2023
Q1 | $2.29M | Buy |
303,470
+84,850
| +39% | +$640K | ﹤0.01% | 1611 |
|
|
2022
Q4 | $2.21M | Buy |
218,620
+24,984
| +13% | +$253K | ﹤0.01% | 1602 |
|
|
2022
Q3 | $1.92M | Buy |
193,636
+3,920
| +2% | +$38.8K | ﹤0.01% | 1645 |
|
|
2022
Q2 | $2.02M | Buy |
189,716
+79,610
| +72% | +$848K | ﹤0.01% | 1744 |
|
|
2022
Q1 | $1.07M | Buy |
+110,106
| New | +$1.07M | ﹤0.01% | 2287 |
|
|
2021
Q4 | – | Sell |
-6,888
| Closed | -$138K | – | 4024 |
|
|
2021
Q3 | $138K | Buy |
+6,888
| New | +$138K | ﹤0.01% | 3703 |
|
|
2021
Q2 | – | Sell |
-2,395
| Closed | -$81K | – | 4381 |
|
|
2021
Q1 | $81K | Buy |
+2,395
| New | +$81K | ﹤0.01% | 4004 |
|